Corium Reports Third Fiscal Quarter 2014 Financial Results
MENLO PARK, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited results from operations for both…